Pharmerging Markets, Led By China, Expected To Keep Sales Growth "Strong" Through 2014, IMS Says

Growth in "pharmerging" markets is so strong it is likely to nearly offset lost sales from genericization of some of pharma's biggest products in the next two years, IMS Health said April 20